UBS Group
HCTI icon

UBS Group’s Healthcare Triangle HCTI Stock Holding History

UBS Group’s Portfolio HCTI Stock Details HCTI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$16K Sell
8,859
-31,856
-78% -$73.5K ﹤0.01% 8296
2026
Q1 		$110K Buy
40,715
+40,588
+31,959% +$494K ﹤0.01% 6965
2025
Q4 		$4.82K Sell
127
-101
-44% -$14K ﹤0.01% 8774
2025
Q3 		$35.9K Buy
228
+227
+22,700% +$59.7K ﹤0.01% 7786
2025
Q2 		$529 Buy
+1
New +$1.7K ﹤0.01% 9801
2025
Q1 		– Hold
0
– – – 9505
2024
Q4 		– Sell
-8
Closed -$58K – 10120
2024
Q3 		$58K Buy
8
+7
+700% +$57.2K ﹤0.01% 6720
2024
Q2 		$6.76K Buy
+1
New +$15.5K ﹤0.01% 7892
2024
Q1 		– Hold
0
– -$1.88K – 9607
2023
Q4 		– Hold
0
– – – 8202
2023
Q3 		– Hold
0
– – – 7666
2023
Q2 		– Hold
0
– – – 7129
2023
Q1 		– Hold
0
– – – 7545
2022
Q4 		– Hold
0
– – – 8850
2022
Q3 		– Hold
0
– -$14K – 10571
2022
Q2 		– Hold
0
– – – 7400
2022
Q1 		– Hold
0
– -$12K – 10506
2021
Q4 		– Hold
0
– – – 8556

Other funds holding HCTI

Bank of Montreal
Bank of Montreal Toronto, Ontario, Canada $304B AUM 35.64% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
DB
Danske Bank Copenhagen K, Denmark $50.6B AUM 42.84% 1-Year Est. Return

UBS Group's HCTI Position: Q2 2026 in Review

UBS Group reduced its Healthcare Triangle (HCTI) stake by 78% in Q2 2026, selling an estimated $73.5K and leaving 8,859 shares worth $16K. The position accounts for ﹤0.01% of the portfolio, ranked #8296.

UBS Group first reported a position in HCTI in Q2 2024 and has held it in 7 quarters since. The position peaked at $110K in Q1 2026. 7 funds tracked by Wall St. Rank hold HCTI as of Q2 2026.

  • UBS Group held 8,859 shares of Healthcare Triangle worth $16K as of Q2 2026.
  • UBS Group sold 31,856 Healthcare Triangle shares in Q2 2026, an estimated $73.5K.
  • Healthcare Triangle made up ﹤0.01% of UBS Group's portfolio in Q2 2026, its #8296 holding.
  • UBS Group first reported a position in Healthcare Triangle in Q2 2024 and has held it in 7 quarters since.
  • UBS Group's Healthcare Triangle position peaked at $110K in Q1 2026.
  • 7 funds tracked by Wall St. Rank held Healthcare Triangle as of Q2 2026.

Based on UBS Group's 13F filing for Q2 2026, filed 13 Aug 2026.